Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle associated 4 pseudogene 3 (CDCA4P3)
- Target
- CDCA4P3
- Molecular classification
- Pseudogene
01
Overview
Cell division cycle associated 4 pseudogene 3 (CDCA4P3) is a human pseudogene, meaning it is a DNA sequence similar to a functional gene (in this case, CDCA4) but is not itself functional and does not encode a protein. Pseudogenes like CDCA4P3 are considered genomic remnants that have lost the ability to produce functional proteins due to mutations or truncations. While some pseudogenes can participate in gene regulation, either by acting as competing endogenous RNAs or being transcribed into regulatory RNAs, there20is no current evidence of such a role for CDCA4P3 specifically. CDCA4P3 is not considered a therapeutic target or involved in any known disease mechanism.
- Other names
- CDCA4P3cell division cycle associated 4 pseudogene 3
02
Mechanism of action
None; no drugs are known to act via CDCA4P3
03
Biological functions
None established for this specific pseudogene; in general, pseudogenes can sometimes regulate gene expression via non-coding RNAs, but there is no evidence for CDCA4P3 specifically
04
Disease associations
None known for CDCA4P3; in general, pseudogenes may be involved in gene regulation and can be implicated in diseases indirectly, but no evidence for this entity currently exists
05
Safety considerations
None; as it is non-coding and non-functional as a protein, there are no known therapeutic or safety issues
06
Interacting drugs
None; pseudogenes do not encode proteins that can be directly targeted by drugs
07
Biomarkers
None
Beyond the preview
Go deeper on Cell division cycle associated 4 pseudogene 3 (CDCA4P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cell division cycle associated 4 pseudogene 3 (CDCA4P3).